Samsung Biologics Co.,Ltd. (KRX:207940)

Samsung Biologics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 28, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	82,212,729	78,463,162	67,544,125	54,092,240	58,433,854	59,746,994
Market Cap Growth	20.20%	16.17%	24.87%	-7.43%	-2.20%	9.32%
Enterprise Value	81,675,729	77,724,732	67,525,830	54,470,491	57,778,382	59,669,231
Last Close Price	1776000.00	1695000.00	1203851.91	964096.37	1041477.78	1133459.52
PE Ratio	50.94	43.98	62.35	63.07	73.22	151.80
Forward PE	47.39	42.21	62.18	60.08	82.37	112.20
PS Ratio	18.04	17.22	14.85	14.64	19.47	38.10
PB Ratio	11.03	10.53	6.19	5.50	6.50	11.97
P/TBV Ratio	11.03	10.53	8.52	8.23	10.14	12.05
P/FCF Ratio	-	-	189.90	80.60	-	1235.91
P/OCF Ratio	-	-	40.71	32.46	61.31	131.43
PEG Ratio	1.53	1.46	3.24	3.45	3.32	3.45
EV/Sales Ratio	17.92	17.06	14.85	14.74	19.25	38.05
EV/EBITDA Ratio	-	-	35.19	33.97	44.72	85.35
EV/EBIT Ratio	39.46	37.55	51.15	48.91	58.74	111.05
EV/FCF Ratio	-	-	189.85	81.16	-	1234.30
Debt / Equity Ratio	0.12	0.12	0.14	0.19	0.28	0.26
Debt / EBITDA Ratio	-	-	0.77	1.19	1.95	1.85
Debt / FCF Ratio	-	-	4.18	2.85	-	26.74
Asset Turnover	0.32	0.32	0.27	0.23	0.24	0.22
Inventory Turnover	-	-	0.83	0.76	0.91	1.02
Quick Ratio	0.57	0.57	0.35	0.50	0.76	1.24
Current Ratio	1.74	1.74	1.43	1.33	1.54	2.55
Return on Equity (ROE)	-	-	10.45%	9.12%	11.42%	8.21%
Return on Assets (ROA)	-	-	4.94%	4.27%	5.01%	4.67%
Return on Invested Capital (ROIC)	17.18%	17.54%	10.06%	9.48%	11.77%	7.98%
Return on Capital Employed (ROCE)	24.30%	24.30%	9.80%	9.40%	7.90%	7.80%
Earnings Yield	2.17%	2.27%	1.60%	1.59%	1.37%	0.66%
FCF Yield	-	-	0.53%	1.24%	-0.01%	0.08%
Buyback Yield / Dilution	-	-	-	-1.95%	-5.51%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.